Related Experiment Video
Updated: Aug 19, 2026

Generation and Multi-phenotypic High-content Screening of Coxiella burnetii Transposon Mutants
Published on: May 13, 2015
Pseudoepidemic of Q fever at an animal research facility
Lisa A Conti1, Thomas R Belcuore, William L Nicholson
1Florida Department of Health, Tallahassee, Florida, USA. lisa_conti@doh.state.fl.us
Abstract:
Serum samples from people exposed to sheep at a research facility were evaluated by a commercial laboratory and resulted in an overall Coxiella burnetii seroprevalence of 75%. We interviewed individuals to determine exposure history and compatible illness, and retested their sera. Analysis indicated that the commercial laboratory was misinterpreting its results; when corrected, the seroprevalence dropped to 27%. Test kits of the brand used by the commercial laboratory gave equivalent results to the in-house CDC assay when tested in parallel at CDC. Upon final analysis, only the attending veterinarian was confirmed as a Q fever case. This event resulted in increased risk reduction protocols at the research facility and improved public health communication among health authorities. This pseudoepidemic resulted from a lapse in laboratory quality control for testing. Similar errors can be avoided through standardization and improved review of laboratory procedures.
Insights
A commercial lab
Area of Science:
- Veterinary Medicine
- Infectious Diseases
- Public Health
Background:
- A commercial laboratory reported a high Coxiella burnetii seroprevalence (75%) in individuals exposed to sheep at a research facility.
- This finding suggested a potential outbreak of Q fever, a zoonotic disease.
- Concerns were raised regarding laboratory quality control and accurate diagnostic testing.
Purpose of the Study:
- To investigate the accuracy of the commercial laboratory's Coxiella burnetii testing.
- To determine the true seroprevalence of Coxiella burnetii in the exposed population.
- To identify the source of discrepancy and implement corrective actions.
Main Methods:
- Retrospective analysis of serum samples initially tested by a commercial laboratory.
- Re-testing of samples using an in-house CDC assay and the same commercial test kits at CDC.
- Interviews with individuals to assess exposure history and compatible illness.
Main Results:
- The commercial laboratory's initial results were found to be misinterpreted, leading to an inflated seroprevalence.
- Corrected analysis revealed a true Coxiella burnetii seroprevalence of 27%.
- Only the attending veterinarian was confirmed as a Q fever case, indicating a pseudoepidemic.
Conclusions:
- A lapse in laboratory quality control caused a pseudoepidemic of Q fever.
- Standardization and improved review of laboratory procedures are crucial for accurate diagnostic testing.
- Enhanced public health communication and risk reduction protocols were implemented at the facility.
More Related Videos
10:29Applying Fluorescence Resonance Energy Transfer (FRET) to Examine Effector Translocation Efficiency by Coxiella burnetii during siRNA Silencing
Published on: July 6, 2016
04:10A Trap-Vaccinate-Release Protocol for Immunization of Skunks and Additional Rabies Vectors Against Rabies
Published on: November 29, 2024